Allarity Therapeutics Inc (ALLR) — Cash Flow-to-Debt Ratio
Allarity Therapeutics Inc (ALLR) has a Cash Flow-to-Debt Ratio of -0.38x as of December 2025, meaning its operating cash flow of $-3.24 Million could theoretically repay 0% of its total liabilities ($8.43 Million) in one year. Explore Allarity Therapeutics Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Allarity Therapeutics Inc Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Allarity Therapeutics Inc across 11 annual periods. Also explore Allarity Therapeutics Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Allarity Therapeutics Inc (2015–2025)
Year-by-year debt coverage analysis for Allarity Therapeutics Inc. For market capitalisation and broader financial context, see ALLR market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.76x | $-14.82 Million | $8.43 Million | ▼ -9.8% |
| 2024 | -1.60x | $-17.35 Million | $10.84 Million | ▼ -83.6% |
| 2023 | -0.87x | $-12.74 Million | $14.61 Million | ▲ +34.4% |
| 2022 | -1.33x | $-16.82 Million | $12.65 Million | ▼ -172.4% |
| 2021 | -0.49x | $-15.05 Million | $30.85 Million | ▲ +55.9% |
| 2020 | -1.11x | $-7.25 Million | $6.55 Million | ▼ -17.1% |
| 2019 | -0.94x | $-10.11 Million | $10.70 Million | ▼ -138.2% |
| 2018 | -0.40x | $-4.24 Million | $10.69 Million | ▲ +49.9% |
| 2017 | -0.79x | $-1.34 Million | $1.70 Million | ▲ +73.4% |
| 2016 | -2.98x | $-3.98 Million | $1.34 Million | ▲ +24.0% |
| 2015 | -3.92x | $-2.03 Million | $518.15K | — |